These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24469503)

  • 1. HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine.
    Zhu XP; Muhammad ZS; Wang JG; Lin W; Guo SK; Zhang W
    Viruses; 2014 Jan; 6(2):371-90. PubMed ID: 24469503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol Enhances Antiviral CD4
    Bagri P; Ghasemi R; McGrath JJC; Thayaparan D; Yu E; Brooks AG; Stämpfli MR; Kaushic C
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and prospects for development of an HSV vaccine.
    Johnston C; Koelle DM; Wald A
    Vaccine; 2014 Mar; 32(14):1553-60. PubMed ID: 24016811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
    Schiffer JT; Gottlieb SL
    Vaccine; 2019 Nov; 37(50):7363-7371. PubMed ID: 28958807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology.
    Sandgren KJ; Truong NR; Smith JB; Bertram K; Cunningham AL
    Methods Mol Biol; 2020; 2060():31-56. PubMed ID: 31617171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
    Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
    Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine value profile for herpes simplex virus.
    Johnston C; Scheele S; Bachmann L; Boily MC; Chaiyakunapruk N; Deal C; Delany-Moretlwe S; Lee S; Looker K; Marshall C; Mello MB; Ndowa F; Gottlieb S
    Vaccine; 2024 Jul; 42(19S1):S82-S100. PubMed ID: 39003018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects and perspectives for development of a vaccine against herpes simplex virus infections.
    McAllister SC; Schleiss MR
    Expert Rev Vaccines; 2014 Nov; 13(11):1349-60. PubMed ID: 25077372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines.
    Stanberry LR
    Herpes; 2004 Aug; 11 Suppl 3():161A-169A. PubMed ID: 15319086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs.
    Quenelle DC; Collins DJ; Rice TL; Prichard MN; Marciani DJ; Kern ER
    Antiviral Res; 2008 Nov; 80(2):223-4. PubMed ID: 18573279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development.
    Xu X; Zhang Y; Li Q
    Rev Med Virol; 2019 Jul; 29(4):e2054. PubMed ID: 31197909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.
    Bernstein DI; Earwood JD; Bravo FJ; Cohen GH; Eisenberg RJ; Clark JR; Fairman J; Cardin RD
    Vaccine; 2011 Mar; 29(11):2071-8. PubMed ID: 21238569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.
    Gottlieb SL; Giersing BK; Hickling J; Jones R; Deal C; Kaslow DC;
    Vaccine; 2019 Nov; 37(50):7408-7418. PubMed ID: 29224963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
    Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.
    Chiuppesi F; Vannucci L; De Luca A; Lai M; Matteoli B; Freer G; Manservigi R; Ceccherini-Nelli L; Maggi F; Bendinelli M; Pistello M
    J Virol; 2012 Jun; 86(12):6563-74. PubMed ID: 22491465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.
    Gallichan WS; Woolstencroft RN; Guarasci T; McCluskie MJ; Davis HL; Rosenthal KL
    J Immunol; 2001 Mar; 166(5):3451-7. PubMed ID: 11207303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection.
    Roth K; Ferreira VH; Kaushic C
    Microb Pathog; 2013 May; 58():45-54. PubMed ID: 23159485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized DNA Vaccine Enhanced by Adjuvant IL28B Induces Protective Immune Responses Against Herpes Simplex Virus Type 2 in Mice.
    Zhou Y; Wang Z; Xu Y; Zhang Z; Hua R; Liu W; Jiang C; Chen Y; Yang W; Kong W
    Viral Immunol; 2017 Oct; 30(8):601-614. PubMed ID: 28650722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.